Bempegaldesleukin (BEMPEG; NKTR-214) efficacy as a single agent and in combination with checkpoint-inhibitor therapy in mouse models of osteosarcoma.
Hennessy M, Wahba A, Felix K, Cabrera M, Segura MG, Kundra V, Ravoori MK, Stewart J, Kleinerman ES, Jensen VB, Gopalakrishnan V, Pena R, Quach P, Kim G, Kivimäe S, Madakamutil L, Overwijk WW, Zalevsky J, Gordon N.
Hennessy M, et al. Among authors: gordon n.
Int J Cancer. 2021 Apr 15;148(8):1928-1937. doi: 10.1002/ijc.33382. Epub 2020 Nov 25.
Int J Cancer. 2021.
PMID: 33152115
Free PMC article.